Oxford University has struck a new collaboration with Serum Institute of India to develop malaria vaccine R78C. The plan targets multiple stages of the malaria parasite to improve effectiveness, while Serum will produce the vaccine at scale. With malaria burden highest across sub Saharan Africa, the pact could accelerate access to a more potent option.
A newly mutated mpox virus traced to Africa has reached Europe and is now moving closer to Pakistan, raising concerns for the region. While authorities say it’s too soon to label it a pandemic, the article urges India to urgently assess vaccine readiness, strengthen outbreak preparedness, and prioritize domestic capacity to respond quickly if cases rise.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
